Abstract
Prospective data now exist demonstrating that trophectoderm biopsy followed by CCS improves the success of IVF by selecting euploid embryos for transfer. Trophectoderm biopsy may also be used when evaluating embryos at risk of inheriting monogenic disorders and has been shown to be safer and more reliable than cleavage-stage biopsy. This study sought to characterize success rates following frozen embryo transfer (FET) of vitrified blastocysts that had been simultaneously screened for aneuploidy as well as a single gene disorder.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
